FURUKAWA-ELECTRIC
Furukawa Electric Co., Ltd. (TOKYO:5801) is launching sales of the new HYC Series heat dissipation products for LED lighting equipment. By achieving lightweight and compact form, the HYC Series reduces the constraints on the seismic design of LED lighting, and in turn it reduces the burden of installation work and the like.
Currently, cast aluminum products and heat dissipation parts comprising lumps of metal including extruded products are commonly used for heat dissipation in LED lighting, but as heat dissipation parts get larger and heavier in keeping with the higher output of LED lighting, problems with LED lighting equipment that is hard to handle as well as constraints on seismic designs are occurring.
This year, Furukawa Electric is fully launching sales of the HYC
Series
lightweight and compact heat dissipation
products designed for LED lighting equipment.
The HYC Series draws
on the heat dissipation/cooling technologies and expertise in
electronics products that Furukawa Electric has developed over many
years, and with this heat dissipation performance, in addition, HYC
Series has been achieved less than half the weight as compared to
conventional cast aluminum and extruded heat dissipation parts. This is
ideal for cooling the high power LED modules that are mainly used in
high ceiling lighting for warehouses, factories, and gymnasiums, as well
as outdoor floodlights and the like.
“It is a pleasure to be able to release HYC Series.” says Ryoji Ono , Corporate Vice President of The Thermal Management Solution & Products Div. ”We will continuously work to provide heat-sink devices which can contribute to people and society”
To start with, Furukawa Electric is launching sales of two types: the HYC 130c (weighing 0.78 kg) 100 – 130 W crimped fin type heat sink, and the 200 W class HYC 200 (weighing 1.2 kg) heat pipe heat sink. Furukawa Electric is planning to add to the lineup going forward in keeping with the further increase of high power LED modules.
About Furukawa Electric Group
Furukawa Electric
(TOKYO:5801)(ISIN:JP3827200001) Group started business in 1884, when its
copper-smelting facility and wire manufacturing factory was established.
Since then Furukawa Electric has become pioneers in the latest
technologies by addressing diverse technological issues.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150125005062/en/
Contact:
EMEA
Furukawa Electric Europe Ltd.
German Office
Jens
Gollata,
+49 2104 952 3601
Sales Executive
jens.gollata@furukawa.co.uk
or
North
and South America
American Furukawa, Inc.
Akira
Hamakawa,
+1-770-798-2008
General Manager, Electronics &
Specialty Division
ahamakawa@americanfurukawa.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release
TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re
Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release
Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release
Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release
Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma
Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release
Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum